Evidence map›Paper›PMID 28074400›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

P Pérez-Segura, J E Palacio, L Vázquez, S Monereo, R de Las Peñas, P Martínez de Icaya, C Grávalos, A Lecube, A Blasco, J M García-Almeida and 2 more

Abstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 12 institutions in 1 country.

P Pérez-SeguraServicio de Oncología Médica, Hospital Clínico Universitario San Carlos, Calle Profesor Martín Lagos, s/n, 28040, Madrid, Spain. pedro.perez@salud.madrid.org.
J E PalacioServicio de Endocrinología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Tenerife, Spain.
L VázquezServicio de Oncología Médica, Complejo Hospitalario de Pontevedra, Pontevedra, Spain.
S MonereoServicio de Endocrinología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
R de Las PeñasServicio de Oncología Médica, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Castellón, Spain.
P Martínez de IcayaServicio de Endocrinología, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain.
C GrávalosServicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, Spain.
A LecubeServicio de Endocrinología, Hospital Arnau de Vilanova, Lleida, Spain.
A BlascoServicio de Oncología Médica, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
J M García-AlmeidaServicio de Endocrinología, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
I BarnetoServicio de Oncología Médica, Hospital Universitario Reina Sofía, Córdoba, Spain.
A GodayServicio de Endocrinología, Hospital del Mar, Barcelona, Spain.
Complejo Hospitalario de Pontevedra · ESConsorcio Hospitalario Provincial de Castellón · ESHospital Arnau de Vilanova · ESHospital Clínico San Carlos · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital Del Mar · ESHospital General Universitario De Valencia · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario 12 De Octubre · ESHospital Universitario Nuestra Señora de Candelaria · ESHospital Universitario Reina Sofía · ESHospital Universitario Severo Ochoa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between obesity and cancer is clear and is present at all times during course of the disease. The importance of obesity in increasing the risk of developing cancer is well known, and some of the most prevalent tumours (breast, colorectal, and prostate) are directly related to this risk increase. However, there is less information available on the role that obesity plays when the patient has already been diagnosed with cancer. Certain data demonstrate that in some types of cancer, obese patients tolerate the treatments more poorly. Obesity is also known to have an impact on the prognosis, favouring lower survival rates or the appearance of secondary tumours. In this consensus statement, we will analyse the scientific evidence on the role that obesity plays in patients already diagnosed with cancer, and the available data on how obesity control can improve the quality of daily life for the cancer patient.

Indexed as

Guidelines as TopicHumansNeoplasmsObesitySpainCancerComorbidityMorbid obesityMortalityNeoplasm recurrenceObesityRisk assessmentSurvival rate

Identifiers

PMID28074400
OpenAlexW2570939418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.